IN8BIO, INC. — Form D/A
IN8BIO, INC. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2018-09-20. The offering totals $10.0M, of which $8.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-20
- Form: D/A
- Accession: 0001740279-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $8.8M
- Remaining: $1.2M
- Investors: 25
- Date of first sale: 2018-05-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-312981
Issuer
- Name: IN8BIO, INC.
- CIK: 0001740279
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: EMPIRE STATE BUILDING, NEW YORK, NY, 10118
- Phone: (646) 600-6438
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Luba R Greenwood | Director | New York, NY |
| Lawrence R Lamb | Executive Officer | New York, NY |
| William Ho | Director | New York, NY |
| William Ho | Executive Officer | New York, NY |
| Jeremy R Graff | Director | New York, NY |
| Kate R Rochlin | Executive Officer | New York, NY |
| Emily R Fairbairn | Director | New York, NY |
| Corinne R Epperly | Director | New York, NY |
| Alan S Roemer | Director | New York, NY |
| Patrick McCall | Executive Officer | New York, NY |
| Travis R Whitfill | Director | New York, NY |
| Emily S Fairbairn | Director | New York, NY |
| Trishna R Goswami | Executive Officer | New York, NY |
| Travis Whitfill | Director | Hummelstown, PA |
| Melissa Beelen | Executive Officer | New York, NY |
| Thomas Cirrito | Director | New York, NY |
| Larry Lamb | Executive Officer | New York, NY |
| Peter Brandt | Director | New York, NY |
| Peter S Brandt | Director | Colorado Springs, CO |
Other filings by this issuer (5)
More